Was Crocodile stronger at Marineford? Or was he holding back in Alabasta?

 During the Alabasta arc, Crocodile displayed a level of power that was initially considered overwhelming by the Straw Hat Pirates. He possessed the Logia-type Devil Fruit called the Suna Suna no Mi (Sand-Sand Fruit), which granted him the ability to control and transform into sand. He had a reputation as a Shichibukai and controlled the desert kingdom of Alabasta from the shadows. His strength was showcased through his battles with Luffy and others. At Marineford, Crocodile was present as part of the war that took place at Marine Headquarters. While he did participate in the battle, he didn't display the same level of dominance as some other powerful characters present. This has led fans to speculate that he might not have been as strong as initially portrayed in Alabasta. It's important to note that power scaling and character abilities can be subject to interpretation and development by the author. Oda often keeps details deliberately open-ended to keep the story intriguing.

What do You Know About the Johnson and Johnson Vaccine Pause in the U.S

Johnson & Johnson vaccine paused over rare blood clots - BBC News


U.S. wellbeing offices required a quick interruption in the utilization of Johnson and Johnson's single-portion Covid-19 immunization after six beneficiaries in the United States built up an uncommon issue including blood clumps inside one to three weeks of inoculation. 

Johnson & Johnson's COVID-19 vaccine safely elicits an immune response

Most states including New York briefly ended or suggested suppliers stop the utilization of the immunization, which almost 7,000,000 Americans have gotten with no other genuine unfavorable responses revealed. CVS and Walgreens additionally said that they would quit managing the shots. 

The Johnson & Johnson vaccine and extremely rare blood clots: What you need  to know - cleveland.com

Less than one out of many Johnson and Johnson immunizations are currently being scrutinized. On the off chance that there is in reality a danger of blood clusters from the immunization — which still can't seem to be resolved — that hazard is incredibly low. The danger of getting Covid-19 in the United States is far higher. 

Company at heart of Johnson & Johnson vaccine woes has series of citations  | PBS NewsHour

The delay could confound the country's inoculation endeavors when numerous states are facing a flood in new cases and trying to address immunization aversion. 

Johnson and Johnson has likewise chosen to defer the rollout of its immunization in Europe in the midst of worries over uncommon blood clumps, managing another hit to Europe's vaccination push.